Johnson & Johnson Services, Inc., Allergan (a subsidiary of AbbVie Inc.) and GC Aesthetics are Dominating in the Global Aesthetic and Cosmetic Surgery Devices Market in 2020

Global Aesthetic and Cosmetic Surgery Devices Market is expected to grow with the CAGR of 7.4% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-aesthetic-and-cosmetic-surgery-devices-market

Global aesthetic & cosmetic surgery devices market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.   

The major players dealing in global aesthetic & cosmetic surgery devices market are introducing strong range of aesthetic & cosmetic surgery devices’ products provider along with launching new aesthetic & cosmetic surgery devices’ products and adopting strategic initiatives such as acquisition, agreement, business expansion, award and recognition into the market. This has helped the companies to maximize the sales with enhanced product portfolio. For instance, in October 2020, GC Aesthetics launched a novel round breast implant named PERLE with BioQ– Surface technology and highly cohesive Emunomic Breast Tissue Dynamic Gel. This new product launched by the company during the emergence of COVID-19 that has increased its credibility in the market.

Johnson & Johnson Services, Inc. is the dominating player in global aesthetic & cosmetic surgery devices market. The other key players existing in the aesthetic & cosmetic surgery devices market are Allergan (a subsidiary of AbbVie Inc.), Airxpanders, Inc., Bonashmedical, Cereplas, Coloplast Corp, DPS Technology Development Ltd, Establishment Labs S.A., GC Aesthetics, Hansbiomed co. Ltd, Ideal Implant Incorporated, Implantech, Koken Co., Ltd., Laboratoires Arion, PMT Corporation, Polytech Health & Aesthetics Gmbh, Rigicon Inc., Sebbin, Shanghai Kangning Medical Supplies Ltd., Sientra, Inc., Silimed, Stryker, Surgisil LLP, Wanhe, Xilloc Medical B.V., Integra Lifesciences, Lipoelastic A.S., Defygravity, Karl Storz Se & Co. Kg among others.

Aesthetic and Cosmetic Surgery Devices Market

Johnson & Johnson Services, Inc.: 

Johnson & Johnson Services, Inc. is headquartered in Titusville, New Jersey and was founded in 1886. The company is focused on personal healthcare used in the beauty, over-the-counter pharmaceutical, baby care, oral care, women’s health, pharmaceutical, medical devices and wound care markets. The company deals in multiple business segments such as consumer, pharmaceutical and medical devices out of which medical devices is the market focused segment. The company has various products under categories which are consumer health products, pharmaceutical products and medical devices in which medical devices is the market focused category.

For instance,

  • In October 2017, Johnson & Johnson Services, Inc. has announced the availability of its MemoryGel Xtra Breast Implants in the United States. This geographical expansion has helped the company to strengthen its footprints in the United States.

The company has presence across Europe, Americas and Asia-Pacific. The company also has various subsidiary companies such as Acclarent, Inc. (Delaware), Actelion Pharmaceuticals US, Inc. (Delaware), Albany Street LLC (New Jersey), ALZA Corporation (Delaware), Alza Land Management, Inc. (Delaware) and others.

Allergan (a subsidiary of AbbVie Inc.):

Allergan (a subsidiary of AbbVie Inc.) is headquartered in Illinois, U.S. and was founded in 2013. The company is focusing on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology, oncology including blood cancers, virology including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease. The company has wide range of products under categories such as central nervous system, eye care, gastroenterology, medical aesthetics and other in which medical aesthetics is the market focused category.

For instance,

  • In October 2020, Allergan has announced that it has agreed with Luminera which is a privately held aesthetics company with a portfolio and pipeline of dermal filler products. It is estimated that this acquisition anticipated strengthening footprints in the Israel market.

The company has wide presence across Asia-Pacific, Europe, Middle East and Africa and Americas. The company also has various subsidiary companies such as AbbVie Biopharmaceuticals LLC (Delaware), AbbVie Products LLC (Georgia), BioDisplay Technologies, Inc. (Illinois), Knoll Pharmaceutical Company (New Jersey), Rowell Laboratories, Inc. (Minnesota), AbbVie S.A. (Argentina), AbbVie PtyLtd (Australia), AbbVie SA (Belgium), AbbVie SAS, (France), AbbVie Biopharmaceuticals Private Limited (India) among others.  

GC Aesthetics: 

GC Aesthetics is headquartered in Dublin, Ireland. The company is engaged in the development and distribution of breast implants used in the aesthetic breast implant surgery or breast reconstruction procedures. The company has various products under categories that are pre-surgery, surgery and post-surgery.

For instance,

  • In July 2020, GC Aesthetics expanded its business in Colombia by launching its implant products in Colombia via its newly established subsidiary named GCA Colombia. This availability of the breast implants of the company in Colombia has expanded its market in the Latin America region.

The company has presence in Latin America, Europe, Asia-Pacific and Middle East and Africa.